NASDAQ:XNPT - XenoPort Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.07 +7.07 (+∞)
(As of 07/6/2016)
Previous Close$7.07
Today's Range$7.07 - $7.07
52-Week Range$3.35 - $7.86
VolumeN/A
Average Volume1.22 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
XenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.

Receive XNPT News and Ratings via Email

Sign-up to receive the latest news and ratings for XNPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
Current SymbolNASDAQ:XNPT
CUSIP98411C10
Phone+1-408-6167200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

XenoPort (NASDAQ:XNPT) Frequently Asked Questions

What is XenoPort's stock symbol?

XenoPort trades on the NASDAQ under the ticker symbol "XNPT."

Has XenoPort been receiving favorable news coverage?

News stories about XNPT stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. XenoPort earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news articles about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days.

What other stocks do shareholders of XenoPort own?

How do I buy shares of XenoPort?

Shares of XNPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is XenoPort's stock price today?

One share of XNPT stock can currently be purchased for approximately $7.07.

What is XenoPort's official website?

The official website for XenoPort is http://www.xenoport.com/.

How can I contact XenoPort?

XenoPort's mailing address is 2000 Seaport Blvd Ste 300, REDWOOD CITY, CA 94063-5584, United States. The biopharmaceutical company can be reached via phone at +1-408-6167200.


MarketBeat Community Rating for XenoPort (NASDAQ XNPT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  146 (Vote Underperform)
Total Votes:  279
MarketBeat's community ratings are surveys of what our community members think about XenoPort and other stocks. Vote "Outperform" if you believe XNPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XNPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel